Palliative Care Issues in Creutzfeldt: Jakob Disease #389

Appleby BS , Cohen ML : Creutzfeldt-Jakob disease. UpToDate. (Last accessed September 20, 2019).

Brown HG , Lee JM : Diseases of the central nervous system caused by prions. UpToDate. (Last accessed October 9, 2019).

National Institute of Health: National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov. (Last accessed October 9, 2019).

Creutzfeldt-Jakob Disease Foundation , Inc.: Supporting Families Affected by Prion Disease . https://cjdfoundation.org. (Last accessed October 9, 2019).

Centers for Disease Control and Prevention: Creutzfeldt-Jakob Disease , Classic. https://www.cdc.gov/prions.cjd. (Last accessed October 9, 2019).

World Health Organization: Transmissable Spongiform Encephalopathies (TSE). https://www.who.int/bloodproducts/tse/en. (Last accessed October 9, 2019).

Brown HG , Lee JM : Biology and genetics of prions. UpToDate. (Last accessed October 9, 2019).

Case Western Reserve University. National Prion Disease Pathology Surveillance Center. https://www.djdsurveillance.com. 2019. (Last accessed October 9, 2019).

Mitchell SL : Care of patients with advanced dementia. UpToDate. (Last accessed October 9, 2019).

Press D , Alexander M : Management of neuropsychiatric symptoms of dementia. UpToDate. (Last accessed September 20, 2019).

Kranitz FJ , Simpson DM : Using non-pharmacological approaches for CJD patient and family support as provided by the CJD foundation and CJD insight. CNS Neurol Disord Drug Targets, 2009; 8:372–379.

Antipsychotic drugs for dementia: A balancing act. Lancet Neurol, 2009; 8:125.

Grassi L , Caraceni A , Mitchell AJ , et al.: Management of delirium in palliative care: A review. Curr Psychiatry Rep, 2015; 17:550.

Crest C , Dupont S , Leguern E , et al.: Levetiracetam in progressive myoclonic epilepsy: An exploratory study in 9 patients. Neurology, 2004; 62:640.

Striano P , Manganelli F , Boccella P , et al.: Levetiracetam in patients with cortical myoclonus: A clinical and electrophysiological study. Mov Disord, 2005; 20:1610.

Nevitt SJ , Sudell M , Weston J , et al.: Antiepileptic drug monotherapy for epilepsy: A network meta-analysis of individual participant data. Cochrane Database Dyst Rev, 2017; 6:CD011412.

Caviness JN : Treatment of myoclonus. Neurotherapeutics, 2014; 11:188.

Obeso JA , Artieda J , Rothwell JC , et al: The treatment of severe action myoclonus. Brain, 1989; 112(Pt 3):765–777.

Obeso JA : Therapy of myoclonus. Clin Neurosci 1995–1996; 3:253–257.

Caviness JN : Treatment of myoclonus. UpToDate. (Last accessed September 20, 2019).

Crain B : Creutzfeldt-Jakob Disease: Safety Tips for Anatomic Studies of Possible CJD. College of American Pathologists Today. 1996.

WHO: WHO CJD infection control guidelines for transmissable spongiform encephalopathies. Report of a WHO consultation, Geneva, Switzerland, March 23–26, 1999.

Medscape: Universal Precautions and High-Risk Autopsies. https://emedicine.medscape.com/article/1711526-overview. 2019. (Last accessed October 20, 2019).

CJD Support Group Network. https://www.cjdsupport.org.au. 2019. (Last accessed October 9, 2019).

CJD Support Network. https://www.cjdsupport.net. 2019. (Last accessed October 20, 2019).